This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Allergic Rhinitis

The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis

Sponsored by National University of Malaysia

About this trial

Last updated 2 years ago

Study ID

FF-2021-421

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Trial Timing

Ended 2 years ago

What is this trial about?

The aim of this clinical study is to compare the efficacy of Elonide Nasal Spray to Nasonex Nasal Spray and Placebo (non-active ingredient) in the management of allergic rhinitis. There are two hypotheses of this study: 1. Elonide nasal spray is same efficacy to Nasonex nasal spray. 2. Elonide nasal spray is more efficient to placebo.

What are the participation requirements?

Yes

Inclusion Criteria

- All adults patients 18 years and above

- Newly diagnosed mild, moderate to severe, intermittent and persistent allergic rhinitis

- Positive skin prick test or serum Immunoglobulin E

No

Exclusion Criteria

- Patients who have been on allergic rhinitis treatment

- Below 18 years old

- Patients diagnosed with asthma or immunodeficiency diseases

- Pregnancy

- Other concomitant rhinology disease

- Smokers

- Severe deviated nasal septum

Locations

Location

Status